Over $1M US in salary, a board seat, STI paid out at 75% and our CMO mucks up her first trial with the smallest population in our clinical investigation roadmap.
Bring on the AGM.
Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-6
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.69M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 28.5¢ | 27.5¢ | $26.78K | 97.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 33316 | 6 |
View Market Depth
| Last trade - 11.30am 11/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |